Search research articles
Contact Us
Filters
Showing results (91-100 of 125) with videos related to
Page
of 13
Sort By:
JTO Clinical and Research Reports
|
March 23, 2026
First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials
Ewa Kalinka, Igor Bondarenko, Miranda Gogishvili, et al.
Emerging Infectious Diseases
|
June 21, 2021
Pneumococcal Disease Outbreak at a State Prison, Alabama, USA, September 1-October 10, 2018<sup>1</sup>
Guillermo V Sanchez, Constance L Bourne, Sherri L Davidson, et al.
Cancer
|
May 5, 2025
Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50
Saadettin Kilickap, Mustafa Özgüroğlu, Ahmet Sezer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2026
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
Cancer Treatment and Research Communications
|
July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapy
Rolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.
Epidemiology and Infection
|
December 7, 2017
Unusually high illness severity and short incubation periods in two foodborne outbreaks of Salmonella Heidelberg infections with potential coincident Staphylococcus aureus intoxication
J H Nakao, D Talkington, C A Bopp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, et al.
Osteoarthritis and Cartilage Open
|
January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial data
Matthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
The Review of Scientific Instruments
|
January 1, 2018
Effects of transients in LIGO suspensions on searches for gravitational waves
M Walker, T D Abbott, S M Aston, et al.
Physical Review Letters
|
April 29, 2017
First Demonstration of Electrostatic Damping of Parametric Instability at Advanced LIGO
Carl Blair, Slawek Gras, Richard Abbott, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 125) with videos related to
Sort By:
Page
of 13
JTO Clinical and Research Reports
|
March 23, 2026
First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials
Ewa Kalinka, Igor Bondarenko, Miranda Gogishvili, et al.
Emerging Infectious Diseases
|
June 21, 2021
Pneumococcal Disease Outbreak at a State Prison, Alabama, USA, September 1-October 10, 2018<sup>1</sup>
Guillermo V Sanchez, Constance L Bourne, Sherri L Davidson, et al.
Cancer
|
May 5, 2025
Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50
Saadettin Kilickap, Mustafa Özgüroğlu, Ahmet Sezer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2026
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
Cancer Treatment and Research Communications
|
July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapy
Rolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.
Epidemiology and Infection
|
December 7, 2017
Unusually high illness severity and short incubation periods in two foodborne outbreaks of Salmonella Heidelberg infections with potential coincident Staphylococcus aureus intoxication
J H Nakao, D Talkington, C A Bopp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, et al.
Osteoarthritis and Cartilage Open
|
January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial data
Matthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
The Review of Scientific Instruments
|
January 1, 2018
Effects of transients in LIGO suspensions on searches for gravitational waves
M Walker, T D Abbott, S M Aston, et al.
Physical Review Letters
|
April 29, 2017
First Demonstration of Electrostatic Damping of Parametric Instability at Advanced LIGO
Carl Blair, Slawek Gras, Richard Abbott, et al.
Page
of 13